Primary Cell Based High Throughput Screening Assay for Agonists of GALR2 NFAT-BLA-CHO cells with the beta-lactamase (BLA) reporter-gene under control of the nuclear factor of activated T-cells (NFAT) promoter were stably transfected with plasmids expressing the rat GALR2. When cells were agonized with galanin/agonist, transcription of the NFAT-BLA gene occurred. The amount of BLA activity was proportional to the concentration of agonist. BLA activity was measured with a fluorescent BLA substrate. Test compounds were screened for activation of GALR2 as measured by BLA activity. Hit compounds were counterscreened to eliminate direct BLA activation. The 5H9 GALR2-NFAT-BLA-CHO cells were cultured in 100 mm tissue culture dish (Corning, part 430167) at 37C and 95% RH. The growth media consisted of Dulbecco's Modified Eagle's Media with GlutaMAX-I (Invitrogen, part 10566-024) containing 10% v/v dialyzed fetal bovine serum (Hyclone, part SH30079.03), 0.1 mM NEAA (Invitrogen, part 1114-050), 1 mM Sodium Pyruvate (Invitrogen, part 11360-070), 25 mM HEPES (Invitrogen, part 15630-080), 1 mg/mL Geneticin (Invitrogen, part 10131-027), 100 ug/mL Zeocin (Invitrogen, part 45-0430) and 1X penicillin-streptomycin (Invitrogen, part 15140-163). Prior to assay, cells were suspended to a concentration of 0.3 million/mL in the assay media (Dulbecco's Modified Eagle's Media with GlutaMAX-I containing 10% v/v dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, and 25 mM HEPES). The HTS assay began by dispensing 10 uL of cell suspension to each well of the assay plates (Griener LV 384-well, part 788092) and incubating for 20 hours. Then 1.1 uL of test compound, DMSO control (for negative control wells) or 10X galanin (10 uM, for positive control wells) was added. The plates were incubated at 37C for 4 hrs and then loaded with 1 uM CCF4/AM. The plates were incubated for 2 hrs at room temperature in dark. Thereafter, the plates were read using the EnVision multi-label reader (PerkinElmer Lifesciences, Turku, Finland) at an excitation wavelength of 405 nm and emission wavelengths of 460 nm & 590 nm. The ratio of 460 nm/590 nm fluorescence emission was calculated. Percent activation was calculated from the median ratio as follows: % activation= ((test_compound - median_negative_control)/(median_postitive_control - median_negative_control))*100 A mathematical algorithm was used to determine nominally activating compounds in the primary screen. Two values were calculated: (1) the average percent activation of all compounds tested, and (2) three times their standard deviation. The sum of these two values was used as a cutoff parameter, i.e. any compound that exhibited greater % activation than the cutoff parameter was declared active. The reported Pubchem_Activity_Score has been normalized to 100% observed primary inhibition. Negative % inhibition values are reported as activity score zero.
bao:BAO_0000812 "1671" ; # "has summary assay" -> "1671"
bao:BAO_0000808 bao:BAO_0000031 ; # "has primary assay" -> "primary assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "beta lactamase reporter gene" ; # "is bioassay type of" -> "beta lactamase reporter gene"
bao:BAO_0000212 bao:BAO_0000125 ; # "has assay method" -> "reporter gene method"
bao:BAO_0000212 bao:BAO_0000151 ; # "has assay method" -> "beta lactamase induction"
bao:BAO_0000207 bao:BAO_0000001 ; # "has detection method" -> "fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Agonists of the galanin receptor 2 (Gal2)" ; # "screening campaign name" -> "Agonists of the galanin receptor 2 (Gal2)"
bao:BAO_0002853 "Primary Cell Based High Throughput Screening Assay for Agonists of GALR2" ; # "has assay title" -> "Primary Cell Based High Throughput Screening Assay for Agonists of GALR2"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000515 ; # "has assay footprint" -> "384 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "25 degree celsius" ; # "substrate incubation temperature" -> "25 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2 hour" ; # "substrate incubation time" -> "2 hour"
bao:BAO_0002833 "4 hour" ; # "has incubation time value" -> "4 hour"
bao:BA0_0090012 "Galanin 1 micromolar" ; # "has participant" -> "Galanin 1 micromolar"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Steven Brown" ; # "material entity assay provider" -> "Steven Brown" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BA0_0090012 "Galanin receptor type 2" ; # "has participant" -> "Galanin receptor type 2"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0002421> ; # "has cell line" -> "CHO cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_10116> ; # "has organism" -> "Rattus norvegicus"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "O08726" ; # "uniprot ID" -> "O08726"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10116" ; # "NCBI taxonomy ID" -> "10116"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% v/v dialyzed fetal bovine serum" ; # "material entity culture serum" -> "10% v/v dialyzed fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 1 mg/mL Geneticin, 100 microg/mL Zeocin and 1X penicillin-streptomycin\"" ; # "material entity culture medium" -> ""DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 1 mg/mL Geneticin, 100 microg/mL Zeocin and 1X penicillin-streptomycin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, and 25 mM HEPES\"" ; # "has assay medium" -> ""DMEM with GlutaMAX-I containing 10% v/v dialyzed FBS, 0.1 mM NEAA, 1 mM Sodium Pyruvate, and 25 mM HEPES""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing the human GalR2 and beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)" ; # "DNA construct" -> "Expressing the human GalR2 and beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)"
bao:BAO_0003105 "galanin receptor 2" ; # "has function" -> "galanin receptor 2"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "8811" ; # "construct gene ID" -> "8811"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0003105 bao:BAO_00020151 ; # "has function" -> "artificial regulatory region"
bao:BAO_0003105 "Nuclear factor of activated T-cells" ; # "has function" -> "Nuclear factor of activated T-cells"
bao:BAO_0003105 bao:BAO_0000751 ; # "has function" -> "Beta-lactamase" || bao:BAO_0003102 bao:BAO_0002656 ; # "has role" -> "reporter gene"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000751 ; # "has participant" -> "Beta-lactamase"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0002153 ; # "has signal direction" -> "signal increase corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000958 ; # "has assay kit" -> "LiveBLAzer FRET - B/G Loading Kit"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000677 ; # "has manufacturer" -> "Invitrogen" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000648 bao:BAO_0000733 ; # "compound library" -> "MLSMR library"
bao:BAO_0002865 bao:BAO_0000701 ; # "uses detection instrument" -> "EnVision Multilabel Reader"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "405 nanometer" ; # "has excitation wavelength value" -> "405 nanometer"
bao:BAO_0002918 "460 nanometer" ; # "has emission wavelength value" -> "460 nanometer"
bao:BAO_0002918 "590 nanometer" ; # "has emission wavelength value" -> "590 nanometer"
bao:BAO_0000337 bao:BAO_0000200 ; # "has percent response" -> "percent activation"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "10" ; # "has concentration value" -> "10"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0002845 "1" ; # "has repetition point-number" -> "1"
bao:BAO_0000196 bao:BAO_0000087 ; # "has mode of action" -> "activation"
bao:BAO_0002864 bao:BAO_0000136 ; # "has repetition throughput" -> "single repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
